Arneja AS1, Kotowich A2, Staley D3, Summers R4, Tappia PS5.
Author information:
1 Rehabilitation Hospital, Internal Medicine, Winnipeg, Manitoba, Canada; Rehabilitation Hospital, Internal Medicine, Winnipeg, Manitoba, Canada.
2 BioResonance Technology Inc., Winnipeg, Manitoba, Canada; BioResonance Technology Inc., Winnipeg, Manitoba, Canada.
3 St. Boniface Hospital Research, Office of Clinical Research, Winnipeg, Manitoba, Canada; St. Boniface Hospital Research, Office of Clinical Research, Winnipeg, Manitoba, Canada.
4 National Research Council, Institute for Biodiagnostics, Winnipeg, Manitoba, Canada; National Research Council, Institute for Biodiagnostics, Winnipeg, Manitoba, Canada.
5 St. Boniface Hospital Research, Asper Clinical Research Institute, CR3129-369 Tache Avenue, Winnipeg, Manitoba R2H 2A6, Canada; St. Boniface Hospital Research, Asper Clinical Research Institute, CR3129-369 Tache Avenue, Winnipeg, Manitoba R2H 2A6, Canada.
Abstract
AIM:
To examine the effects of low-amplitude, low frequency electromagnetic field therapy (EMF) therapy in patients with persistent chronic lower back pain associated with degenerative disc disease.
DESIGN:
Double-blind, randomized and placebo controlled.
INTERVENTION:
EMF using a medical device resonator; control group underwent same procedures, except the device was turned off.
OUTCOME MEASURES:
Pain reduction and mobility.
RESULTS:
Improvements in overall physical health, social functioning and reduction in bodily pain were observed in the EMF group. The pain relief rating scale showed a higher level of pain relief at the target area in the EMF group. An increase in left lateral mobility was seen only in the EMF group.
CONCLUSION:
EMF treatment may be of benefit to patients with chronic nonresponsive lower back pain associated with degenerative disc disease.
